Skip to content

A Critical Study of Nabhi and Effect of Nabhi Poorana with Murchhita Ghrita in Drishtimandya in the context of Presbyopia

A Critical Study of Nabhi and Effect of Nabhi Poorana with Murchhita Ghrita in Drishtimandya in the context of Presbyopia - nil

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085505
Enrollment
100
Registered
2025-04-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H542- Low vision, both eyes Health Condition 2: H542- Low vision, both eyes

Interventions

None listed

Sponsors

Dr Rashmi Bhandekar P
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Persons with only presbyopia in the age group of 40 to 60 will be selected (after optometric examination done by opthalmologist,optometrist,shalakya dept)

Exclusion criteria

Exclusion criteria: - persons above the age of 60 and below the age of 40 - any other eye disorder - persons with HT, DM, Hormonal issues, infective diseases of eye - inflammatory conditions of eye

Design outcomes

Primary

MeasureTime frame
IMPROVEMENT IN SUBJECTIVE AND OBJECTIVE PARAMETERS subjective parameters- 1.blurring of vision while performing near task 2.dificulty in performing near task 3.straining of eyes while performing near task 4.watering from eyes while performing near task 5.headache after performing near task 6.dryness of eyes while or after performing near task 7. itching or pricking sensation while or after performing near task OBJECTIVE PARAMETER- Improvement in optic power number Timepoint: patient will be revied after 15 days and after one month

Secondary

MeasureTime frame
nilTimepoint: nil

Countries

India

Contacts

Public ContactDr Arun Mishra

Mandsaur university,Madhya pradesh

arunmisra2007@gmail.com8880981003

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026